Android app Apple app link

Acrivon Therapeutics Inc (ACRV) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$1.53

$0.05 (-3.16%)
Last update: 06:16 PM EST
Day's range
$1.52
Day's range
$1.58

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
11/14/2024 BMO Capital Etzer Darout $27.00 $7.92   240.91%
09/16/2024 BMO Capital Etzer Darout $28.00 $8.91   214.25%
08/13/2024 Oppenheimer Matthew Biegler $18.00 $7.26   147.93%
05/14/2024 Oppenheimer Matthew Biegler $21.00 $8.36   151.2%
05/14/2024 H.C. Wainwright Emily Bodnar $22.00 $8.35   163.63%
05/14/2024 BMO Capital Etzer Darout $25.00 $8.51   193.77%
04/25/2024 Piper Sandler Joseph Catanzaro $30.00 $9.20   226.09%
04/25/2024 JMP Securities Silvan Tuerkcan $17.00 $9.50   78.95%
03/28/2024 H.C. Wainwright Emily Bodnar $20.00 $7.19   178.36%
12/11/2022 Piper Sandler Joseph Catanzaro $25.00 $12.50   100%

Acrivon Therapeutics Inc FAQ's

Acrivon Therapeutics Inc has been rated by research analysts at BMO Capital, Oppenheimer, H.C. Wainwright, Piper Sandler, JMP Securities, Jefferies in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.